Creative BioMart provides various immune checkpoint products including immune checkpoint proteins, immune checkpoint antibodies, immune checkpoint ELISA kits, immune checkpoint IP kits as well as immune checkpoint cDNA clones (>700 immune checkpoint products) to academia and industries. Creative BioMart provides several outsourcing contract research services for immune checkpoint drug development including immune checkpoint protein expression, immune checkpoint protein purification, immune checkpoint antibody discovery, immune checkpoint inhibitors functional assay, immune checkpoint binding & interaction assay and quantitative immune checkpoint protein analysis. Creative BioMart mainly focuses on cancer immunotherapy which has rapidly developed in recent years. Creative BioMart applies Crispr-Cas 9 technology into immunotherapy and firstly builds a Crispr-Cas 9 platform as a CRO for knocking out negative immune checkpoint genes in T cells via electroporation method to reduce R&D cost and reduce the risk of failure for academia and pharmaceutical industries during immune checkpoint inhibitor discovery process.
Creative BioMart is dedicated to be a more professional and experienced immune checkpoint CRO company all over the world and hopes to provide more immune checkpoints related services and products to customers. Based on our immune checkpoint services and platform, Creative BioMart hopes to contribute more R&D work on immune checkpoints to develop new immune checkpoint drugs for cancer patients. Now, Creative BioMart is devoted to find more immune checkpoint targets and related biomarkers. Moreover, we are also building new platform about biomarkers of immune checkpoints because biomarkers can help determining and predicting the effectiveness of treatments and also play an important role in guiding clinical drug use. At last, Creative BioMart is recruiting more experienced researchers on the field of immunotherapy to perfect products and services.